Comparing the effects of intravenous Lignocaine and Ketamine on postoperative pain after Ear, Nose and Throat surgeries.

Comparison between the effects of intravenous Lignocaine & Ketamine on postoperative pain after Ear, Nose and Throat surgeries. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/055969

Enrollment

Registered

2023-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous Lignocaine 1.5mg/kg: Intravenous Lignocaine 1.5mg/kg bolus after induction followed by 1.5mg/kg/hr continuous infusion till completion of surgery Control Intervention1: Intr

Eligibility

Inclusion criteria

Inclusion criteria: ASA class I and II

Exclusion criteria

Exclusion criteria: Patients requiring postoperative mechanical ventilation or regional analgesia Patients on perioperative gabapentin, magnesium Pregnant or breastfeeding mothers BMI more or equal to 35kh/sq meter Allergy or contraindications to study medications. Patients with cardiac, renal or hepatic disease. Patients with seizure or other neurological disorder. Patients with chronic preoperative opioid use or substance abuse and history of chronic pain.

Design outcomes

Primary

Measure	Time frame
Pain assessed post operativelyTimepoint: Assessment of pain immediately post op, 1hour, 6hour, 12hour and 24hour.	—

Secondary

Measure	Time frame
First & total rescue analgesia (paracetamol) consumedTimepoint: 24 hours post-operatively.	—

Countries

India

Contacts

Public ContactDr Ahswini H R

Karnataka institute of medical sciences, Hubbali

ashvenki.hubli@gmail.com9480553670

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026